All for Joomla The Word of Web Design
18
August Monday

 The Cuban ministry of public health ( MINSAP by its Spanish acronym) reported today that 38,953,180 anti-COVID-19 doses have been administered in the country, with its own vaccines, Soberana 02, Soberana Plus and Abdala.

Keeping COVID-19 under control is not the only challenge facing the Cuban health system, but also Dengue Fever since in summertime Aedes aegypti mosquitoes increase transmission of arboviruses.

 A total of 9,975,994 people have already been administered the COVID-19 vaccines Soberana 02, Soberana Plus and Abdala, which means that 90% of the Cuban population is immunized, according to the Ministry of Public Health (MINSAP).

Cuban President Miguel Díaz-Canel praised today the success of the COVID-19 pediatric immunization program launched in the country in preventing any decease among children and shared the results of a study by the Pedro Kourí Tropical Medicine Institute proving that, during the Omicron surge, the vaccine Soberana was 90.1% effective in the 2 to 5 age group and 95.8% in children between the ages of two and eighteen.

Cuban Minister of Public Health (MINSAP) José Ángel Portal Miranda urged to reinforce prevention and individual responsibility to tackle COVID-19 in light of the slight increase in the infection rate in the last four weeks, including 298 new cases in the past seven days.

After undergoing desperation due to acute pain derived from Lithiasis (formation of stony concretions in the urinary tract or gallbladder), Cuban Alfredo Villalon living in this eastern city, praised the benefits of a new local medication to fight that condition, based on Potassium Nitrate and Critic Acid.

Cuban health ministry (MINSAP by its Spanish acronym) reported today that 9,975,414 people (90 %) have completed the anti-COVID-19 vaccination program, with the immunogens developed in the country, Soberana 02, Soberana Plus and Abdala.

Cuban President Miguel Díaz-Canel praised today on Twitter the upcoming start of clinical trials of the national drug against Alzheimer's, NeuralCIM (NeuroEPO) and remarked that Cuban science and innovation continue to contribute to the country's development.

More Articles ...